Acute coronary syndrome
270 results
1 - 100
Acute coronary syndrome - Essentials
- Follow-up management
- Symptoms and clinical diagnosis
- References
- Diagnostic investigations
- Initial management
- Treatment of UAP and NSTEMI
- Treatment of STEMI
- Arrhythmias associated with myocardial infarction
- Right ventricular infarction
- Acute coronary syndrome triggered by other factors
- Inpatient treatment
Presence of risk factors doesn't predict acute coronary syndrome
Statins for acute coronary syndrome- Hyperbaric oxygen therapy for acute coronary syndrome
- Statins for acute coronary syndrome
- Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
- Clinical decision helpful in diagnosis of acute coronary syndrome in primary care
- Escitalopram reduces risk of adverse cardiac events in adults with depression and acute coronary syndrome
- PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES)
- For treatment of acute coronary syndrome, prasugrel is better than ticagrelor at preventing recurrent MIs at 1 year
- Early CT angiography for suspected acute coronary syndrome reduces further ischemic testing; no effect on long-term clinical outcomes
- Chronic coronary syndrome (coronary heart disease)
- Dabigatran associated with increased risk of coronary events
- Patients with non-ST-elevation acute coronary syndromes do not need immediate intervention
- Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes: Cochrane systematic review
- Additional testing of limited benefit in patients with new-onset chest pain
- Coronary CT angiogram allows for safe discharge of low-risk patients with chest pain
- FDA: Clopidogrel/aspirin does not decrease overall mortality
- Faster discharge but more downstream testing with use of CCTA in ED
- HET score: atypical chest pain + normal ECG + normal troponin = no acute coronary event
- Genotype-guided selection of oral P2Y12 inhibitor therapy no better than standard therapy after PCI for ACS or stable CAD
- For atrial fibrillation with ACS or PCI, apixaban plus clopidogrel (without aspirin) is preferred (AUGUSTUS)
- Ruling out acute myocardial infarction based on patient characteristics
- Intensive lipid lowering reduces mortality following ACS
- Bivalirudin = abciximab + heparin for non-STEMI
- Pain severity does not predict outcomes with AMI
- Intensive lipid lowering adds additional benefit
- Signs and symptoms not helpful in diagnosis of AMI/ACS
- Improved outcomes with early invasive strategy for ACS? Maybe, maybe not.
- Low-dose rivaroxaban improves outcomes in patients with ACS (ATLAS)